Gilead Sciences has issued a voluntary recall of one lot of its COVID-19 treatment Veklury (remdesivir) after discovering glass particles in the vials. The company received a customer complaint prompting an investigation that confirmed the presence of foreign material in the affected lot. Gilead is notifying distributors and customers, urging them to stop using the recalled lot and return any remaining vials.